Spect, a provider of end-to-end eye disease screening solutions, has received $3.5 million in series seed financing, led by Morado Ventures, XTX Ventures, 10X and AME Cloud, Opthalmology Times reports
The company’s AI-enabled mobile telemedicine platform helps clinicians capture retinal images and screen for vision-threatening eye diseases, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD) — at a reduced cost using medical assistants and nurse practitioners in primary care and at-home care. Read more.
